Vomiting clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy
open to eligible people ages 30 months to 18 years
Chemotherapy-induced nausea and vomiting (CINV) are among the most bothersome symptoms during cancer treatment according to children and their parents. Most children receiving highly emetogenic chemotherapy (HEC), including those receiving…
at UCSF
Our lead scientists for Vomiting research studies include Christopher Dvorak.
Last updated: